Volume 52, Number 2
A study group from Taiwan investigated drug-drug interactions in patients with nonvalvular atrial fibrillation, a type of irregular heartbeat.
They concluded that the concurrent use of particular inducers increases the risk of bleeding events.
Illustration by Nata Blackthorn
Editorial
Direct oral anticoagulant: Looking beyond convenience
Since the 2010 Food and Drug Administration approval of Dabigatran as the first non-vitamin-K antagonist oral anticoagulants or direct oral anticoagulants (DOACs) as it...
Editorial
Breast cancer-related lymphedema (BCRL): Should we be doing more or less for the axilla?
Breast cancer mortality has declined steadily over the years with breast cancer screening, and improvement in diagnostic and therapeutic regimens. Despite cancer survivors living...
Original Article
Effect of drug interactions with non-vitamin-K oral anticoagulants on thromboembolic events in patients with nonvalvular atrial fibrillation
Atrial fibrillation (AF), a type of arrhythmia for which the incidence and prevalence are rising in the older population, has become a global epidemic.1...
Original Article
Defining breast cancer-related lymphedema (BCRL) prevalence and risk factors: A pragmatic approach to lymphedema surveillance
Breast cancer-related lymphedema (BCRL) is a chronic progressive pathological condition of the lymphatic system that can lead to significant impact on the quality of...
Original Article
Frailty-aware surgical care: Validation of Hospital Frailty Risk Score (HFRS) in older surgical patients
Frailty is a clinically recognisable state of vulnerability in older people, resulting from age-associated decline in physiological reserves and function across multiple organ systems,...
MOST CITED ARTICLES
MOST VIEWED ARTICLES
Letter to the Editor